Aptazapine Uses, Dosage, Side Effects and more
Aptazapine (CGS-7525A) was a tetracyclic antidepressant developed in the 1980s. Aptazapine had noradrenergic and specific serotonergic activity. It antagonised α2 adrenergic receptors approximately 10 times more effectively than mianserin, antagonised 5-HT2 receptors, agonised H1 receptors, and did not affect reuptake of serotonin or norepinephrine. Although Aptazapine reached clinical trials, it was never marketed.
| Attribute | Details |
|---|---|
| Trade Name | Aptazapine |
| Generic | Aptazapine |
| Aptazapine Other Names | Aptazapine |
| Type | |
| Formula | C16H19N3 |
| Weight | Average: 253.349 Monoisotopic: 253.157897624 |
| Groups | Experimental |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for the treatment of depression.
Innovators Monograph
Search Medicines
